A sweeping genomic effort in Taiwan has revealed something that global precision medicine has long overlooked, that the best way to predict disease is to study the people who will be living with its consequences. Researchers at Academia Sinica have now shown that building genetic risk tools tailored to Han Chinese populations can transform how common illnesses are forecast and understood.
In work published in Nature on October 15, 2025, scientists analyzed genomic and clinical data from more than half a million participants in the Taiwan Precision Medicine Initiative. By conducting the largest genome wide association analysis of Han Chinese individuals to date, they developed the first population specific polygenic risk score models for diseases ranging from type 2 diabetes to autoimmune disorders to heart disease, achieving markedly stronger accuracy than tools based on European data. “This project marks a milestone for precision medicine in East Asia,” said Dr. Cathy S. J. Fann, senior corresponding author at Academia Sinica. “By integrating large scale genomic and clinical data, we are building predictive models that truly reflect the real genetic architecture of our population.”







